SalaryGuide
AboutPricingFor Employers

Marketing jobs

5 marketing jobs

Dexcom logo
2 weeks ago

HCP Marketing Manager (Stelo)

Dexcom

California, MO (Remote)Full time$106K/yr – $176K/yr
Dexcom logo
4 weeks ago

Global Brand Marketing Manager (Stelo)

Dexcom

California, MO (Remote)Full time$106K/yr – $176K/yr
Dexcom logo
3 months ago

Associate Marketing Manager

Dexcom

San Diego, CA (Hybrid)Full time$83K/yr – $138K/yr
Dexcom logo
3 months ago

Associate Marketing Manager, Web Operations

Dexcom

San Diego, CA (Hybrid)Full time$83K/yr – $138K/yr
Dexcom logo
4 months ago

Associate Marketing Manager, Global

Dexcom

USA (Remote)Full time$83K/yr – $138K/yr

All marketing roles in the US

Get alerts for this search

All marketing roles in the US

Get alerts for this search

5 jobs
Dexcom logo

HCP Marketing Manager (Stelo)

Dexcom

California, MO (Remote)

$106K/yr - $176K/yrIn-houseFull-timeSenior level8+ years exp.
2 weeks ago
Dexcom logo

Global Brand Marketing Manager (Stelo)

Dexcom

California, MO (Remote)

$106K/yr - $176K/yrIn-houseFull-timeMid level8+ years exp.
4 weeks ago
Dexcom logo

Associate Marketing Manager

Dexcom

San Diego, CA (Hybrid)

$83K/yr - $138K/yrIn-houseFull-timeMid level5+ years exp.
3 months ago
Dexcom logo

Associate Marketing Manager, Web Operations

Dexcom

San Diego, CA (Hybrid)

$83K/yr - $138K/yrIn-houseFull-timeMid level5+ years exp.
3 months ago
Dexcom logo

Associate Marketing Manager, Global

Dexcom

USA (Remote)

$83K/yr - $138K/yrIn-houseFull-timeMid level5+ years exp.
4 months ago
Dexcom logo
Dexcom

HCP Marketing Manager (Stelo)

California, MO (Remote)

$106K/yr – $176K/yrSenior Level8+ years expFull time

Posted 2 weeks ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own and drive the HCP marketing strategy for Dexcom Stelo, translating clinical value into compliant messaging, planning and executing paid media campaigns, and enabling field teams while partnering with Medical, Legal, and Regulatory to ensure timely approvals and lead generation across digital touchpoints.

  • Own the HCP marketing strategy and messaging across channels
  • Lead cross-functional approvals and compliant asset development

Job Description

Responsibilities

  • Support development and execution of the Stelo HCP marketing strategy, ensuring alignment to brand positioning, portfolio priorities, and business
  • Translate clinical and product value into clear, compelling, and compliant HCP messaging across channels
  • Plan and execute HCP-focused paid media campaigns (programmatic, endemic, paid social, paid search, etc) in partnership with internal media lead and agency teams
  • Ensure consistent brand and message delivery across all HCP touchpoints to deliver personalized, compelling experience that creates action
  • Develop and maintain HCP sales enablement tools, including visual aids, brochures, presentations, digital assets, and field resources
  • Support Stelo HCP website, email and paid media content development for Stelo, including ongoing optimization of provider pages, educational content, and conversion pathways
  • Drive HCP lead generation through digital campaigns, email journeys, website forms, events, and affiliate programs
  • Serve as a primary marketing partner to Medical, Legal, and Regulatory teams to ensure timely, compliant development and approval of HCP assets

Requirements

  • Bachelor’s degree in Marketing, Business, or related field
  • 5+ years of experience in healthcare, medical device, pharmaceutical, or regulated marketing
  • Experience developing HCP marketing strategies across paid media, digital, and sales enablement
  • Strong working knowledge of MLR processes and regulated promotional environments
  • Proven ability to manage multiple projects and stakeholders simultaneously
  • Excellent communication, collaboration, and execution skills

Benefits

  • A front row seat to life changing CGM technology. Learn about our brave #dexcomwarriors community .
  • A full and comprehensive benefits program.
  • Growth opportunities on a global scale.
  • Access to career development through in-house learning programs and/or qualified tuition reimbursement.
  • An exciting and innovative, industry-leading organization committed to our employees, customers, and the communities we serve.
Dexcom logo

Dexcom

3.7 Glassdoor

Empowering People to Take Control of Health Dexcom Corporation (NASDAQ DXCM) has been a pioneer in glucose sensing for more than 25 years. Since 1999, we have developed innovative technologies that transformed how people manage diabetes. Our products are part of people’s daily lives, empowering them to live confidently and feel more in control, free to pursue their dreams. Headquartered in San Diego, California, with operations around the world, Dexcom leads by listening to the needs of users, caregivers, and providers, to simplify and improve glucose management.

Founded in 1999
San Diego, California, US
7.8K employees (293 in marketing)
careers.dexcom.com/careers/index
68% recommend to a friend
81% CEO approval

Traffic Signals

Monthly Visitors
2.4M
Monthly Google Ads Budget
$211.9K
Traffic Source Mix
Search
36.7%
Direct
50.2%
Referral
7.3%
Social
3.8%
Paid
1.9%

Headcount Trend

Current headcount: ~8.1K

Marketing Team

Marketing Team Size
233 (3% of company)
Median Career Experience
14 years
Median Tenure
3.8 years
Marketing Roles Posted (Last 30 Days)
2

People

HR / Recruitment

Fiona McLoughlin
Fiona McLoughlin
Head of Talent Acquisition @ Dexcom - Ireland
At the company for 2 years 7 months
Therese Valerie Reyes
Therese Valerie Reyes
Head of Talent Acquisition - APAC (except Malaysia)
At the company for 3 years 11 months

Marketing Leadership

Anne Santoro
Anne Santoro
SVP, Product Marketing
At the company for 9 years 11 months
Fiona McLoughlin
Fiona McLoughlin
Head of Talent Acquisition @ Dexcom - Ireland
At the company for 2 years 7 months
Therese Valerie Reyes
Therese Valerie Reyes
Head of Talent Acquisition - APAC (except Malaysia)
At the company for 3 years 11 months
Afsaneh Sadri
Afsaneh Sadri
Head of Product Marketing, Stelo by Dexcom
At the company for 4 years 10 months

Funding

Total Funding
$2.2B
Last Raise
Post IPO Debt, 3 years ago

Recent News

Sensor Patch Market Size is Expected to Reach $56.4 Billion by 2032 | DexCom,, Medtronic PLC
Mar 12, 2025 • EIN Presswire
Glucose Biosensor Market Booming with Technological Advancements | Industry Insights Abbott Laboratories, Dexcom, Sanofi
Mar 12, 2025 • EIN Presswire
Health Sensors Market Projected to Hit USD 316.14 Billion by 2034, at a Exceptional CAGR 18.50%
Mar 11, 2025 • EIN Presswire
Why Dexcom Is On A Six-Day Losing Spree — But This Analyst Isn't Worried
Mar 10, 2025 • Investor's Business Daily
DexCom continues decline following FDA warning letter
Mar 10, 2025 • Seeking Alpha
Dexcom receives FDA warning letter over CGM manufacturing issues
Mar 10, 2025 • sdbn.org
Automated insulin delivery systems are safe and effective for older adults with type 1 diabetes
Mar 10, 2025 • News-Medical
Dexcom Appoints Renée Galá to Board of Directors
Mar 10, 2025 • Business Wire
Tech-heavy Nasdaq suffers worst day since 2022 with $1 trillion wiped out
Mar 10, 2025 • Business Insider
Appointments and advancements for March 10, 2025
Mar 10, 2025 • BioWorld Financial Watch
Continuous Glucose Monitoring Market to Hit USD 8.82 Billion by 2032 | SNS Insider
Mar 3, 2025 • EIN Presswire
3 Growth Stocks to Buy and Hold Forever
Mar 1, 2025 • The Motley Fool
Dexcom Announces Upcoming Conference Presentation
Feb 27, 2025 • Business Wire
Medical device recalls hit a four-year high in 2024. Here’s why
Feb 27, 2025 • Modern Healthcare
Got $200? 2 Healthcare Stocks to Buy and Hold Forever
Feb 26, 2025 • The Motley Fool
Why non-diabetics using CGM may not be a good idea
Feb 26, 2025 • pharmaphorum
This stock has 'multiple drivers of upside for 2025': analyst
Feb 25, 2025 • StreetInsider.com
Dexcom’s FY2024 Up 11% Over ‘23
Feb 25, 2025 • San Diego Business Journal
Healthcare: A compelling argument to take advantage of the volatility
Feb 21, 2025 • QuotedData
Why are pharma, medical device and DTx companies investing in telemedicine?
Feb 4, 2025 • Healthcare IT News
How to keep profiting from this health-care stock that's breaking out
Jan 29, 2025 • Investing
As Super Bowl nears, TV data show GLP-1 game day ads enjoyed a big year
Jan 24, 2025 • Fierce Pharma
Larry Magid: Testing prescription, over-the-counter continuous glucose monitors
Jan 23, 2025 • The Mercury News
DXCM's Preliminary Results Show Strong Growth: How to Play the Stock?
Jan 22, 2025 • Yahoo Finance
Dexcom Helps People With Diabetes Take the First Step to Discover What They’re Made Of on World Diabetes Day
Nov 14, 2024 • Business Wire
Will glucose monitors become the next wellness accessory?
Oct 30, 2024 • Press Telegram
Will glucose monitors become the next wellness accessory?
Oct 30, 2024 • Sun Sentinel
Dexcom posts mixed-bag earnings report amid Stelo rollout, CCO departure
Oct 25, 2024 • FierceBiotech
These Analysts Revise Their Forecasts On DexCom Following Q3 Results
Oct 25, 2024 • TradingView
CGMs Aren’t Just for People with Diabetes Anymore, Dexcom COO Says
Oct 25, 2024 • MedCity News
Why DexCom Stock Flopped on Friday
Oct 25, 2024 • The Motley Fool
Dexcom Crashes As A Key Executive Plans Departure Amid Stelo Launch
Oct 24, 2024 • Investor's Business Daily
Dexcom stock tumbles 16% post-market amid Q3 earnings report (NASDAQ:DXCM)
Oct 24, 2024 • SeekingAlpha
DexCom Q3 earnings beat estimates, but stock tumbles 16% on weak growth
Oct 24, 2024 • Investing.com
DexCom options imply 9.0% move in share price post-earnings
Oct 24, 2024 • thefly.com
Glucose monitor maker Dexcom beats quarterly sales estimates, backs annual forecast
Oct 24, 2024 • MarketScreener
DexCom Stock Drops After Q3 Results, Announces C-Suite Transition
Oct 24, 2024 • Benzinga
The Gross Law Firm Notifies DexCom, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - DXCM
Oct 7, 2024 • PRNewswire
Is DexCom a Millionaire Maker?
Oct 5, 2024 • The Motley Fool
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit
Oct 1, 2024 • PRNewswire
DXCM STOCK UPDATE: Investors of DexCom, Inc. are Alerted of Imminent October 21 Deadline; Contact BFA Law if You Lost Money (Nasdaq:DXCM)
Sep 29, 2024 • EIN News
Is DexCom a Millionaire Maker?
Sep 25, 2024 • The Motley Fool
DexCom put volume heavy and directionally bearish
Sep 20, 2024 • thefly.com
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit
Sep 20, 2024 • Morningstar
DXCM FRAUD ALERT: A Securities Fraud Lawsuit has been Filed against DexCom, Inc. – Investors are Notified to Contact BFA Law before October 21 Deadline (Nasdaq:DXCM)
Sep 17, 2024 • Morningstar
Dexcom data: CGM for type 2 diabetes without insulin treatment
Sep 12, 2024 • http://www.zdnet.com/
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit
Sep 12, 2024 • PRNewswire